Formycon Delay Pushes Back Coherus’ Ranibizumab

FDA Requests Additional Data On Lucentis Rival

 
• By David Wallace
  
Delayed
Formycon and Bioeq's US Ranibizumab Application Has Been Delayed • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products